
    
      This is an interventional, non-controlled, multicenter trial with a prospective design in one
      cohort of patients. This clinical investigation will be performed in 3 centers in Romania.

      The tested hypothesis is that PhysiomannaÂ® Baby administration for 3 weeks, increases the SBM
      to be more than 2 times per week.
    
  